IL6 and glioblastoma: Intratumor delivery of IL-6 blockade was unable to reprogram the glioblastoma TIME or prolonging survival, even when combined with PD-1 blockade (Extended Data Fig. 7), suggesting that blockade of IL-6 from sources outside the TIME is required for treatment efficacy.